education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Indonesia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Indonesia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
MIMS home
Drugs
Info
Irbosyd
Irbosyd
mebeverine
Produsen:
Fahrenheit
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Bahasa Concise Prescribing Info
Komposisi
Mebeverin HCl.
Indikasi/Kegunaan
Irritable bowel syndrome.
Dosis/Cara Penggunaan
1 tab 3 x/hr.
Pemberian
Dapat diberikan bersama atau tanpa makanan : Lebih dianjurkan utk diberikan 20 mnt sblm makan atau bersama makanan.
Perhatian Khusus
Ggn jantung; ggn fungsi hati, peny ginjal stadium lanjut. Hamil & laktasi. Anak <10 thn.
Efek Samping
Ggn pencernaan, rasa panas pd ulu hati, pusing, insomnia, anoreksia, sakit kepala, bradikardi, konstipasi, rasa tdk enak badan.
View
ADR Monitoring Form
Klasifikasi MIMS
Antispasmodik
Klasifikasi Kimiawi Terapeutik Anatomis
A03AA04 - mebeverine ; Belongs to the class of synthetic anticholinergics, esters with tertiary amino group. Used in the treatment of functional bowel disorders.
Klasifikasi menurut Peraturan
G
Bentuk Sediaan/Kemasan
Form
Irbosyd Tab salut selaput 135 mg
Packing/Price
30's (Rp75,000/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in